FADS1 and metastatic neoplasm: We also found that in kidney cancers, FADS1 mRNA levels demonstrated a significantly gradient elevation from adjacent normal tissue, primary RCC tumors, metastatic tumors to recurrent tumors [7], highlighting its potential role in cancer biology and disease progression.